RECOVER aims to:

– Determine the effect if TCMT on pulmonary function in children and adults with CF over a period of 2 years.

– Determine the effect of TCMT on spirometry-controlled CT scores in children and adults with CF over a 2-year period. 

– Investigate the effect of TCMT on airway infection and inflammation in children and adults with CF.​

– Assess the effect of TCMT on nutrition, gastrointestinal symptoms, gut inflammation and pancreatic functions in children and adults with CF over a 2-year period. ​

– Determine the effect of TCMT on antibiotic treatment of pulmonary disease in children and adults with CF over a 2-year period. ​

– Assess the impact of the introduction of TCMT on adherence with overall medical treatments for CF.